Empowering Early Discovery of Peptide Drugs
In this webinar, our experts discuss recent advancements in peptide drug discovery, including the evolution of mRNA display and peptide DNA-encoded library (DEL) technology for hit generation and selection, as well as novel cyclization techniques and their combinations for peptide conformational rigidity.
This webinar offers a comprehensive perspective on strategies that are crucial for achieving the desired binding affinity and efficacy for developing potent and orally available peptide drugs.
Related Content
The heme oxygenase (HO) family comprises the major isozymes HO-1 and HO-2, of which HO-1 is deemed as an emerging...
VIEW RESOURCEThe safe production of cultivated plants is threatened by various fungal diseases. NIS1 is a secreted effector protein produced by...
VIEW RESOURCE